Search | COVID-19

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia.

Deodato, Marina; Frustaci, Anna Maria; Sportoletti, Paolo; Laurenti, Luca; Murru, Roberta; Visentin, Andrea; Reda, Gianluigi; Mauro, Francesca Romana; Quaresmini, Giulia; Vanazzi, Anna; Vitale, Candida; Orsucci, Lorella; Massaia, Massimo; Sanna, Alessandro; Motta, Marina; Ibatici, Adalberto; Ferrarini, Isacco; Borella, Chiara; Varettoni, Marzia; Tani, Monica; Marinoni, Sara; Ferrario, Andrea; Zamprogna, Giulia; Montillo, Marco; Tedeschi, Alessandra.

Leuk Lymphoma ; : 1-4, 2022 Mar 27.

Article in English | MEDLINE | ID: covidwho-1764353

The management of chronic lymphoproliferative disorders at the time of SARS-Covid2 pandemic: weathering the storm.

Frustaci, Anna Maria; Zamprogna, Giulia; Deodato, Marina; Cairoli, Roberto; Montillo, Marco; Tedeschi, Alessandra.

Leuk Lymphoma ; 61(13): 3278-3279, 2020 12.

Article in English | MEDLINE | ID: covidwho-670377

Subject(s)

COVID-19 , Lymphoproliferative Disorders , Severe Acute Respiratory Syndrome , Humans , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/epidemiology , Lymphoproliferative Disorders/therapy , Pandemics , SARS-CoV-2

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL